Condition
Neurocardiogenic Syncope
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed4
Terminated2
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05514756Not ApplicableCompleted
VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment.
NCT02154009Terminated
Clinical Autonomic Disorders: A Training Protocol
NCT01617616Completed
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
NCT02009982Not ApplicableCompletedPrimary
Cardioneuroablation for Neurocardiogenic Syncope
NCT00060866Phase 4CompletedPrimary
Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance
NCT00143754Phase 3Terminated
Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope
Showing all 6 trials